Chris Kaganzev

Chris Kaganzev is an accomplished professional with extensive experience in contracts, pricing, and government programs within the pharmaceutical industry. Currently serving as the Executive Director of Contracts and Pricing at Supernus Pharmaceuticals, Inc. since September 2013, Chris has previously held senior management roles at Genentech and CSL Behring, where responsibilities included managing government pricing calculations, resolving pricing discrepancies, and overseeing government contracts personnel. Chris's career also includes key positions at Sanofi-Aventis Pharmaceuticals and Scott-Levin, focusing on Medicaid rebate processing and regulatory monitoring. Academic achievements include a Doctorate in Business Administration from Thomas Edison State University and an MBA from the University of Maryland, complemented by a Bachelor's degree from Kutztown University of Pennsylvania.